title: Quantitative proton magnetic resonance spectroscopy of childhood adrenoleukodystrophy.
abstract: Cerebral metabolic disturbances in patients with childhood adrenoleukodystrophy (ALD) were assessed by quantitative localized proton MRS. Patient monitoring by follow-up MRS studies served to identify putative markers for disease onset and progression. Whereas normal-appearing white matter of neurologically asymptomatic patients is characterized by slightly elevated concentrations of choline-containing compounds (Cho), an increase of both Cho and myo-inositol (Ins) seems to indicate the onset of demyelination. Markedly elevated concentrations of Cho, Ins, and glutamine in affected white matter reflect active demyelination and glial proliferation. A simultaneous reduction of the concentrations of N-acetylaspartate and glutamate is consistent with neuronal damage or loss. The observation of elevated lactate is in line with inflammation and/or macrophage infiltration. The more severe metabolic disturbances in cerebral ALD correspond to progressive demyelination, neuroaxonal loss and gliosis leading to clinical deterioration and eventually death. The detection of MRS abnormalities before the onset of neurological symptoms may help in the selection of patients for bone marrow transplantation (BMT). Stabilization and partial reversal of metabolic abnormalities is demonstrated in a patient after BMT.
authors.affiliation: Biomedizinische NMR Forschungs GmbH am Max-Planck-Institut für biophysikalische Chemie, Göttingen, Germany.
authors.forename: P J
authors.initials: PJ
authors.lastname: Pouwels
authors.forename: B
authors.initials: B
authors.lastname: Kruse
authors.forename: G C
authors.initials: GC
authors.lastname: Korenke
authors.forename: X
authors.initials: X
authors.lastname: Mao
authors.forename: F A
authors.initials: FA
authors.lastname: Hanefeld
authors.forename: J
authors.initials: J
authors.lastname: Frahm
mesh_terms: D000293:Adolescent; D000326:Adrenoleukodystrophy / Q000145:classification* / Q000378:metabolism* / Q000628:therapy; D000328:Adult; D016026:Bone Marrow Transplantation; D001921:Brain / Q000378:metabolism*; D002648:Child; D002675:Child, Preschool; D018450:Disease Progression; D005500:Follow-Up Studies; D006801:Humans; D007231:Infant, Newborn; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D018579:Patient Selection; D011446:Prospective Studies